Pancreas Adenocarcinoma
Conditions
Keywords
pancreatic head adenocarcinoma; total mesopancreas excision;pancreaticoduodenectomy
Brief summary
The study of extended total mesopancreas excision(eTME) for pancreatic head adenocarcinoma is a retrospective multicenter cohort, collecting medical records and follow-up data of patients who underwent radical resection with pancreatic head adenocarcinoma.
Detailed description
The objectives of the study are as follows: 1. To evaluate the perioperative safety of extended total mesopancreas excision(eTME) for patients who diagnosed with resectable pancreatic head adenocarcinoma. 2. To demonstrate the prognosis of extended total mesopancreas excision(eTME) for patients who diagnosed with resectable pancreatic head adenocarcinoma.
Interventions
None listed
Sponsors
Ruijin Hospital
Shanghai Zhongshan Hospital
Shanghai Jiao Tong University School of Medicine
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
1. Patients with pancreatic head adenocarcinoma who underwent curative-intent resection. 2. Patients with accessible medical records
Exclusion criteria
1. Patients with unknown chemotherapy sequence or status 2. Patients with history of previous malignant tumors 3. Patients with distant metastases
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall survival | 5 years | The overall survival data were defined by (date of death)-(date of first diagnosis).The survival status of patients were retrieved from follow-up. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Disease free survival | 5 years | The overall survival data were defined by (date of recurrence/progression)-(date of surgery).During follow-up period, abdominal enhanced CT, chest X-ray, tumor markers and routine blood tests were carried out to evaluate recurrence/progression. |
Countries
China
Contacts
Primary ContactYingbin Liu, Ph.D.
Outcome results
None listed